Kenneth Cunningham, a director at $VRNA, sold 10,808 shares of the company on 08-01-2025 for an estimated $142,057. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.9% of their shares of this class of stock. Following this trade, they now own 79,776 shares of this class of $VRNA stock.
$VRNA Insider Trading Activity
$VRNA insiders have traded $VRNA stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.
Here’s a breakdown of recent trading of $VRNA stock by insiders over the last 6 months:
- DAVID ZACCARDELLI (President and CEO) has made 0 purchases and 9 sales selling 1,686,280 shares for an estimated $17,163,687.
- MARK W HAHN (Chief Financial Officer) has made 0 purchases and 9 sales selling 1,686,280 shares for an estimated $17,163,092.
- KATHLEEN A. RICKARD (Chief Medical Officer) has made 0 purchases and 6 sales selling 336,168 shares for an estimated $3,192,153.
- ANDREW FISHER (General Counsel) has made 0 purchases and 4 sales selling 195,656 shares for an estimated $1,967,695.
- VIKAS SINHA has made 0 purchases and 4 sales selling 184,328 shares for an estimated $1,738,229.
- CHRISTINA ACKERMANN has made 0 purchases and 2 sales selling 41,808 shares for an estimated $361,363.
- MICHAEL AUSTWICK sold 11,288 shares for an estimated $148,366
- MARTIN EDWARDS sold 10,808 shares for an estimated $142,057
- KENNETH CUNNINGHAM sold 10,808 shares for an estimated $142,057
- LISA DESCHAMPS sold 9,464 shares for an estimated $124,391
- MAHENDRA SHAH sold 3,608 shares for an estimated $47,422
- DAVID R EBSWORTH sold 1,904 shares for an estimated $25,025
- JAMES ALOYSIUS BRADY sold 824 shares for an estimated $10,830
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNA Hedge Fund Activity
We have seen 147 institutional investors add shares of $VRNA stock to their portfolio, and 120 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 3,849,724 shares (+230.9%) to their portfolio in Q1 2025, for an estimated $244,418,976
- DARWIN GLOBAL MANAGEMENT, LTD. added 3,112,755 shares (+384.1%) to their portfolio in Q1 2025, for an estimated $197,628,814
- NEA MANAGEMENT COMPANY, LLC removed 2,896,188 shares (-51.9%) from their portfolio in Q1 2025, for an estimated $183,878,976
- RA CAPITAL MANAGEMENT, L.P. removed 1,766,830 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $112,176,036
- HOLOCENE ADVISORS, LP added 1,366,680 shares (+inf%) to their portfolio in Q1 2025, for an estimated $86,770,513
- MAVERICK CAPITAL LTD removed 1,345,018 shares (-43.0%) from their portfolio in Q1 2025, for an estimated $85,395,192
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,292,575 shares (+381.9%) to their portfolio in Q1 2025, for an estimated $82,065,586
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRNA Analyst Ratings
Wall Street analysts have issued reports on $VRNA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wolfe Research issued a "Outperform" rating on 07/01/2025
- Piper Sandler issued a "Overweight" rating on 06/23/2025
- Wells Fargo issued a "Overweight" rating on 06/20/2025
- Roth Capital issued a "Buy" rating on 06/18/2025
- Cantor Fitzgerald issued a "Overweight" rating on 06/11/2025
To track analyst ratings and price targets for $VRNA, check out Quiver Quantitative's $VRNA forecast page.
$VRNA Price Targets
Multiple analysts have issued price targets for $VRNA recently. We have seen 10 analysts offer price targets for $VRNA in the last 6 months, with a median target of $107.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $107.0 on 07/14/2025
- Tiago Fauth from Wells Fargo set a target price of $107.0 on 07/10/2025
- Suji Jeong from Jefferies set a target price of $107.0 on 07/09/2025
- Edward Nash from Canaccord Genuity set a target price of $107.0 on 07/09/2025
- Andy Chen from Wolfe Research set a target price of $170.0 on 07/01/2025
- Yasmeen Rahimi from Piper Sandler set a target price of $160.0 on 06/23/2025
- Boobalan Pachaiyappan from Roth Capital set a target price of $116.0 on 06/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
